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The use of the alimentary route to supply essential 
nutrients., either by mouth or nasogastric tube, is by far 
the best.. 1'his route? hO'i.vever, requires an intact an<l func-
tioning gastrointestinal tract which may not be :found in 
certain chronic intestinal diseases, malignant tumors, and 
cases of gastrointestinal obstruction.. In these ancl certain 
other clinical situations, parenteral feeding is necessary 
-r.70 provide essential nutrients normally provided in the diet .. 
The intravenous route of administration is gene~cally 
recognized as the most e:ffecti ve means of systemic administra·~ 
tion., Yet, considering the other routes used clinically, it 
is of relativel~· recent development.. Parenteral therapy began 
in 1616 'tvith the discovery of the circulatory system by the 
Rag1ish physician William Harv:3y (1).. In 1656, Sir Christopher 
Wren successfully gave intravenous injections to dogs (2) .. 
Later years savv experimentation with attempts at parenteral 
therapy, especially blood transfusions, ·with little or no 
success... It was not until the early nineteenth century that 
Thomas Latta, in Scotland, used saline vdth great success to 
treat the intractable diarrhea o:f cholera.. He is considered. 
to be the first man to use intravenous· injection in terms of 
rational therapy (2) .. 
In the search for effective means of parenteral :rnitri-· 
tion, various ing:eedients v1ere infused into animals and man .. 
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In 1873, EdT,vard Hodder success.fully injected milk into man (3) .. 
The intravenous injection o.f glucose for nutritional purposes 
was first accomplished by Kausch in 1911 (L~).. The most sig-~ 
nLficant discovery for parenteral therapy was that of Francis 
Siebert who in 1923 discovered the cause of pyrogens in dis-
t;illed water (5).. In 1937, Rose's (6) identification of the 
amino acids essential .for the grmvth of the rat \vas a signifi-
cant step for parenteral nutrition.. This discovery led to the 
development of the first protein hydrolysates for intravenous 
use in mana Meng and co-workers (7) studied parenteral nutri-
t:ion in dogs.. They injected carbohydrates., fat 9 protein~ 
minerals, and vitamins for as long as ten weeks at a time .. 
It v1as :Dudrick (8) v1ho ma.de the me.jor b:r:-eakthrongh for p,SJr-
enteral nutrition in 196'7.. He demonstrated, with the use of 
six beagle puppies, that the simultaneous administration of 
glucose and a nutritionally balanced mixture of amino acids 
~from a protein hydrolysate, \vith added minerals and vitamins, 
vJOuld support an anabolic state~ Muscular and skeletal grmvth 
'I.;Je:ce normal., as was body chemistry., 
The terms intravenous or parenteral h;y-peralimentation 
are often used to describe this procedure because of the 
hyperor:;molarity of the solution.. More recently., total par-
enteral rn1tritio:n. (TPN) has 'l?een used by various authors .. 
Burke (9) has defined this method as the intravenous adminis-
tration of proteins, calories, essential intracellular ions 
and other nutrients sufficient to achieve tissue synthesis 
and an anabolic state in patients v.rhere oral feeding is 
-- ---- --- - --
--------------- ·--
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impossible or, alone, inadequate.. Flack and co-workers (10) 
have defined it in slightly different terms.. They describe 
the process as the intravenous administration of sufficient 
nutrients above the.usual basal requirements to achieve tissue 
synthesis, positive nitrogen balance, and anabolism .. 
A variety of protein hydrolysates 1-Jhich differ not 
only the starting protein but also their mode of preparation 
·have been used.. Geyer (21) has reported that<:~ originally~ 
inve-stigators conducted experiments on hydrolysates of meat, 
.fibrin, and milk<» Casein or fibrin hydrolysates are e:;cten-
s::Lve.Ly used at the present, but those prepared from lactalbumin, 
bovine serum protein and human serum albumin have reportedly 
been investigated .. a)-1 posBible alternatives, 
Ravin (13) has divided the clinical indications .for 
parenteral hyperalimentation into five general categories: 
1$ Patients who cannot eat: 
Esophageal carcinoma 
Gastric carcinoma 
Obstructive peptic ulcer 
Paralytic ileus, etc@ 
2.. Patients \vho should not eat: 





Laryngeal incompetence~ etc .. 
3.. Patients 'lrJho \vill not eat enough: 
Postoperative geriatic patients 
Anorexia nervosa, etc .. 
4.. Patients who cannot eat enough: 
Multiple .fractures 
Major full-thickness burns 
Ulcerative colitis 
Short bovrel syndrome 
Malabsorption synd..'t'ome, etc .. 
5@ Infants who have congenital anomalies or 
chronic diarrhea~· 
In oral alimentation, essentially all dietary protein 
is hydrolysed to the free. amino acids. The digestive enzymes 
of the gastrointestinal tract do contribute to his, but the 
major end products of their action are small peptides.. These 
are resolved into free amino acids by peptidase present in 
the mucosal .lining of the small intestine.. Therefore~ if the 
dietary source is restricted or insufficient in one or more 
of the essential amino acids, tissue protein synthesis for 
gro\,vth and healing will be restricted and some of the amino 
acids vdll enter cat;abolic pathways leading to .formation and 
excretion of nitrogen.3 primarily in the form of urea (9)., In 
healthy indi vi.duals, a :fe\v days of reduced nutritional intake 
is of little consequence, but ;,,rhen a patient is subject to major 
trauma or disease~ catabolism occurs at a much faster rate (16) .. 
For example, if a patient is m1.der physiological stress due to 
infection or trauma, the caloric requirement increases to 3,000 
to '+~000 calories per day (22) .. 
NUJ~RIT I m,TAL RF.:Q!-JIREll/fENTS 
-------~- • r ' 
f-ro·~e:bn~ and JIJI?.J£.2 __ Acids. 
There are many nitrogen sources that have been used 
(15); amino acids~ protein hydrolysates, albumin, plasma, 
and. vJhole blood .. Albumin, plasma? and 'ti1hole blood have been 
quite useful in restoring and maintaining intravascular oncontic 
pressure~ bu·t; the protein provided in this mmmer must undergo 
time and energy consuming conversions to amino acids for protein 
synthesis.. Until .fairly rece.ntly, crystalline amino acids 
r: 7 
· have been too costly when adequately refined for intravc:)nous 
use.. Therefore, protein hydrolysates .from enzymatic hydrolysis 
o.f casein or .fibrin have been the major sources of intravenous 
nitrogen (see Table I).. These solutions provide about 6096 of 
the available nitrogen as ·amino acids and 40% as dipeptides 
and tripeptides (15).. The importance of maximum amh10 acid 
content and minimum polypeptic1e content has been established,. 
Ho1.vever, no controlled clinical studies? comparing the effieacy 
of protein hydrolysates and s;ynthetic amino ac:lds, can be found 
i:;::. the literature.. Asch'i ~-Cil., (38), in i'ive infants and tvro 
small child:ren receiving alternate courses of therapy with 
casein hydrolysate e..nc1 thq s;ynthot:ic amino acid solution, 
found little difference vlith regard to nit~cogen balance and 
\Height gain'* However, the small number of patients prevents 
any meaningful statistical inference .. 
Tv1enty-t1.vo amino acids (11) are ordinarily requir·ed 
.for synthesis o.f tissue proteins, and the absence of any one 
of them could. prevent the .formation of a polypepticle.. \1Tith 
no intake of any essential amino acid~ tism:te synthesis will 
~ mh .L.h · · · t · t th J 1 no..:; occur, ~ e sym ... es~s 1.ncreases J..n propor J..On o , _ e .evG. 
o.f the amino acid.s vrhich is fed, up to an optimal point (12) .. 
The '?96 Protein Hydrolysate Injection u .. s .. P., a used il?-
this study is an aqueous solution of a pancreatic (porcine) 
enzymatic digest o.f casein~ It has been fortified by the 
a - C.,P .. H .. , Cutter Laboratories, Berkele;y? Ca .. 
TABLE I 
Solutions Available Commercially 
For Parenteral Hyperalimentation 
--------------------------------- --------------·------------------Basic Solution 
8o5% Crystalline ~~ino Acidsa 500 ml 
plus 50% Dextrose to make 1000 ml 
5% Fibrin Hydrolysateb 750 ml 
plus 50% Dextrose to make 1000 ml 
7% Casein Hydrolysate0 590 ml 
plus 50% Dextrose to make 1000 ml 
10% Casein Hydrolysated 500 ml 
plus 50% Dextrose to mru{e 1000 ml 




5 .. 06 
6 .. 10 
6.,80 
b - Aminosol, Abbott Laboratories, North Chicago, Ill .. 
c- C@PQHo, Cutter Laboratories, Berkeley, Gao 
d - Hyprotigen, ~IcGaw Laboratories, Glendale, Ca .. 
III.MIJ'iTINP.P'' 1', ,\1".\l~] .. p lf!'., \![1, •• fl •• I ,,,, I 
Total Protein 
Equivalent Gm/L 
39 .. 1 
31.,6 
38 .. 1 
4-2.5 




addition of quantities of met.?ionine, tryptophan, and 
phenylalanine.. It is interesting that itlunner and co--workers 
(23) have reported that tryptophan causes a non-specific 
increase in the rate of protein synthesis and net deposition 
of protein associated with an increase in polyribosomes and 
a decrease in monoribosomes in the liver., Conversely, fee<l-
ing a mixture deficient in other amino acids 9 did not decrease 
liver protein synthesis in the normal animal.. Each 100 ml of 
C .. P.,.H .. conto.ins 4-.,89 Gm pro·cein hydrolysate \vhich contains all 
the essent·ial ·amino acids in the follo'~,ring approximate amounts, 
·?::::pressed in Gm/L: 
Leucine 4 .. 15 Arginine 1 .. 5 
Va.l:Lne .? .. 0 Threonine 1.,8 
Lysine 3o5 Methionine 2 .. 2 
Isoleucine 2 .. 4 Histadine 1 .. 2 
Phenylalanine 2,.3 Tryptophan 0.,5 
In addition, the follOi,ving non-essential amino acids are 
present as a result of the enz;:;vmatic digestion of casein: 
glutamic acid, proline~ serine, aspartic acid, cystine 9 alanine, 
tyrosine';) and aminoacetic acid.. The pH has been adjusted with 
lactic acid to about 5 .. 3a Electrolytes are {ound. in the formu-
lation in the following respective mEq/L ion concentrations: 
sodium 23') potassium 11? calcium Lf., chloride 8, and phospltate 8<> 
Estimates have been made on the protein and amino acid 
requirements of man (16,17).. Based on these ni·[;rogen balance 
studies, an intake of O .. L~5 Gm protein per Kg body i.'leight i.·mulcl 
be needed by the average adult to cover urinary, fecal, 
8 
cutaneous, and other minor routes of nitrogen excretion (18) .. 
DeMaeyer and Vanderbrought (19) have calculated that a child 
of 3 to 5 years needs an average of 0 .. 6 to 0.7 Gm of protein per ~ 
Kg body \veight.. There are few relevant studies on the protein 
requirements among the elderly.. Kountz and co-1vorkers (20) 
sugges·t; that t;heir requirements for nitrogen equilibrium 
averages 0 .. 6 Gm per Kg body \•reight .. 
C §£._1? q,J;l_;zd;ra t e s 
In addition to the protein/amino acid requirements, 
an. additional source of calories is requi:eecL. Preaston (lLJ-) 
has stated that 25 to 30 cal/Kg are required daily for main-· 
tenanc_e purposes alone& In a 70 Kg man~ the body usually 
sto:r,es approximately 100 to 200 Gm o.f carbohydrates chiefly 
in the .form of glycogen which may be utilized in 2L~ hours or 
less (12).. After exhaustion o:f these stores 9 breakdown o:f 
bod.y tissue occurs unless adequate calories are supplied,. 
Thi.s :r•esults in muscle "I!'Jasting, delayed ·wound healing, lmv-ered 
resistEDJce to infection, and prolonged convalescen<:re (14).. It 
has been recommended that an extra 13% o.f caloric requirement 
be added :for the hyperthermic patient for each clegree centi-
g:cade above normal body temperature (14·).. Consid.eri:ng the 
caloric cont~e:nt of each of the three energy sources 9 fat is 
by far the best, yielding 9 cal/Gm of fat -v;hich. can be admin-· 
istered as an emulsion (soya bean oil emulsified by egg phos··· 
phatide made isotonic with glycerin).. Carbohydrates BJ.'ld protein 
each yield L~ cal/Gm (14)... It appears to make little difference 
whether the calories are administered as fats, carbohydrates~ 
------
------------
or even alcohol, provided that at least 150 calories are 
supplied per Gm of nitrogen (protein or amino acid) infused 
(15) ... Hypertonic dextrose offers the most inexpensive and 
practical caloric source at the present time .. 
~ 
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The mineral requirement can be divided into ·hro major 
classifications: major electrolytes and trace elements" ~!he 
major electrolytes would include sodium, chloride? bicarbonate, 
potassium, calcium., magnesium, phosphate 9 and possibly sulfate,. 
Trace elements include: iron, zinc., copper, ioclicle, fluoride, 
ch:r·omiu.m 1 cobalt, manganese 9 molybdium 1 selenium., and vanadium 
(2~-) .. 
Sodium, po·i;assium, and chloride ion~~ a:ee probably the 
most crit:~cal of the electrolyte additives.. It has been 
reported (2L~) that their concentrations should be monitorea. 
daily a.nd sometimes more freql).ently in cases of serious elec-
trolyte and fluid imbalances., Therefore, no single value or 
range can be followed, as the requirements ""ill vary depending 
on renal, cardiovascular? and endocrine condition of the 
patient.. The .following additive levels have been reported 
as average adults doses in hyperalimentation: sodium. (as 
chloride) 40-50 mEq/L, potassium (as chloride) 30-40 mEq/L, 
and chloride 50 mEq/L (10,26)o 
Potassium .Plays an essential role in the transportation 
of glucose and amino acids across the cell membrane (27)., Also'} 
if this ion is not administerea_, potassium from the bloodstream 
will be used to accompany glucose and amino acids into the cell, 
10 
creating a serum deficiency.. Grant, rt_al.. (27) report that 
as much as 160 to 200 mEq of potassium may be given with 1~,000 
calories for effectiv-e utilization of the carbohydrate.. There-
fore, increased amounts of glucose and amino acids administra·-
tion would seem to require increased amount of potassium in 
order to be absorbed by the cell and to maintain the proper 
electrolyte balanceo 
There appears to be no hormonal mechanism for control-
ling serum magnesium levels (24).. Normally., serum levels must 
be dependent primarily on intake and excretion through the 
kinney., It is the second most plentiful cation within cellu-
lar fluids (28)~ Guyton (29) states that magnesium is required 
as a ce.talyst for many in:t.racellular enzymatic :reactions~ par-
ticularly those relating to carbohydrat;e metabolism"' The 
recommended daily allowance for an adult; on total parenteral 
:nut:ritio:n has been reported as 25 mEq/day (2L~) or~ on the 
liter basis, 8 mEq/L (26),; It is usually admixed into the 
solution as the sul.fate salt~ 
Calcium ion has been commonly added as the gluconate 
or glucoheptonate salt.. Calcium is reported to be normally 
present; in small quantities in the extracellular fluid and to 
a minor extent·in the structure and cyt;oplasm of cells of soft 
tissue (28).. Calcium is also essential for muscle contraction, 
nerve condition~ and blood coagulation.. Davidson· (30) states 
that the bulk of the body's calcium and phosphorus is located 
in the bones.. This accounts for 9996 of the total calcium and 
80 to 85% of the total phosphorus, ~;,rhich is in combination 
11 
with calcium .. The remaining phosphorus (i.e .. , phosphate) 
· exists as a major anion of j_ntracellular .fluid.. The phos-
phate ion is generally admixed in the form of potassium acicl 
phosphate .. 
Casein hydrolysates are reported to have 100 to 125 
mg/L of calcium, approximately six times ·that of fibrin hyd:ro-
lysates (2L~).. There are approximately 10 mg/L of phosphorus 
as inorganic phosphate in the .fibrin, as compared .to 200 mg 
of phosphorus as :free inorganic phosphate in the casein hydro-
lysate .. 
There have been t·wo schools of thought concerning the 
addition of· calcium and phosphate to hyperalimentation solu--
tions., Some a.uthorities believe ·l.:;her!:; they shoula_ be addecl 
routinely and others believe the serum leveJ_s should be 
.follo'tved and the ions added \vhen ind.:i.cated.. The actual sig-~ 
ni.ficance o:f calcium administration has been questiom~(l because 
of the development of distise osteoporosis in patients vJ"ho are 
beQcidden for long periods of time (31, 32).. These conditions 
result· in increased urinary and fecal calcium levels@ Some 
authorities also feel that administration of calciUt"'ll is neces-
sary \<Then phosphate is given in order to prevent hypocalcemia .. 
Allen and co--workers (33) have reported hypocalcemia in some 
hypophosphat;emic patients given phosphorus in doses of L~ to 
8 mEq over eight; hours.. Inorganic phosphate is required for 
the production of high energy organic phosphates.. Lotz (3L~) 
and ~Lichtman (35) have reported symptoms in hypophosphatemia 
such as malaise, muscle wealrn.ess, and mental depression., 
12. 
Kaminiski (26) has expressed the approximate adult requirement 
for calcium to be 10 mEq/L and phosphate to be 20 rnEq/L., 
Sulfur present in methionine, cysteine, and taurine 
(23) is apparently suff'icien-t; to :form ot;her sulfur containing 
compounds provided the supply of these amino acids is sufficient .. 
To supply the trace elements, some authorities (25) 
feel "!:;he periodic infusion of plasma or blood. is suT:ficient 
for normal body needs.. Dudrick, §.t~'ll· (36) and Doolas (37) 
- have stated that trace elements are needed only a:f·ter one mm::rtih 
of treatment 1,vith total parenteral nutrition .. 
Vitamins 
-........ ~-'"""' .... -
Guyt;on (29) has defined a vitamin as an organic com-
pound needec1 in small quantities for operation of normal bodily 
metabolism and that cannot be manufactured in the cells of the 
body., Greene (39) stated that since they are intimately involved. 
in metabolism of carbohydrates, proteins, and fat., they are an 
essential additive to complete :parenteral nutrition., 
The use of an injectable multiple vitamina consisting 
of ascorbic acid, vitamin A, vitamin :0~ thiamine HCl, riboflavin, 
pyridoxine HCl., niacinard.de, dexpanthenol, ana. vitamin E has 
resulted in vitamin A and D toxicity (40,4-l)., To avoid this, 
it has been recommended that a change be made to a combination 
o.f B complex with ascorbic acid b after about five days of total 
parenteral nutrition (L~2) .. 
a~·· N .. V .. I .. , U.,.S .. V .. Pharmaceutical Corp .. , Tuckahoe, N, Y .. 
b - Solu···B Forte, The Upj ohn Company, Kalamazoo, r1ich .. 
~: 
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Optional additives, v~hich depend upon the clinical 
indications are phytonadione, cyanocobalamin~ and folic acid 
(10,13).. r1cGovern {22) has reported the ao.dition of corti-
cost;eroids in some cases of inflammatory enteritis" 
Geyer (L~L!-) has stated that lm·T doses of insulin v1ere 
given to aid sugar uptake by the tissues~ thereby decreasing 
urinary loss.. Doolas stated (37) that exogenous insulin is 
not usually required, since endogenous insulin production is 
- stimulated by dextrose and. most; amino aci(is.. He further states 
that in the early postoperatbre periocl, insulin may be needed, 
si:-we postope:cative patients de·v·elop a transient elevation in 
blood glucose.. Diabetic patients, of course, will require 
exogenous insuJ.ino DeBch.epper (!+5) he.s reported that insulin 
enhances intracellular utilization of amino acids in protein 
synthesis, rather than increase the net upta'ke of amino acids" 
It has been reported (1-I-6) that the ad.dition of insulin to intra-
venous systems has resulted in 23-2896 adsorption of the drug 
to glass and plastic (46).. The reported levels of regular 
insulin used range from 20 to L~O units per liter (l~2 ,27) .. 
CO~~ATIBILITY STUDIES 
-- .............. ---
There are very fev.J scientific studies on the com:pati-
bility of hyperalimentation solutions reported in the li-t;era-
ture.. Because of this, there is little or no data on. 1-rhich 
to base decisions of compatibility and/or stability of various 
adraixtures.. Those studies that are available are either the 
result of a ·personal experience? 'i'vithout controls, or conjee-
ture on what would be expected .. 
Cluxton (L~) has elaborated on the complexities of 
making compatibility studies on hyperalimentation. solutions .. 
He cites the variability of each formula as well as variation · 
in concentration of each ingredient as a problem in experi-
mental design.. He points out that it is dangerous to assume 
that because there is no evidence of physical incompatibility, 
that a solution is compatible .. 
Patel and P'.r:tillips (L~5) compiled a compatibility chart 
based on published articles and actual experimentation.. Their 
stud.y consisted of mixing difi'erent solutions on a glass slide 
an.c,_ examining the slicte under a microscope.. bvaluation of 
physical compatibility was based on the clarity of the result-
ing solu:t;:Lon~ This stu.dy pointed out the:t orcler o~r mixing cen 
affect the· compatib:i.lity.. Chlortetracycline, n:i:t;rofurantoi:o.? 
novobiocin, pentobarbital sodiu.rn, and thiopental sodium 'l.vere 
:fou:o.d to be incompatible with protein hydrolysates .. 
Pelissier and Burgee (L~6), in a compilation of informa-· 
tion from published articles, manufacturers~· intravenous com-
patibil:i:ty charts, manufacturer's package inserts, and bro-
chures, report that albumin (human), aminophylli.n, sodium 
salts of barbiturat:es, Gedilanid-D, chlortetracycline, corti.·~ 
cotropin, digitoxin, digoxin, (liphenhydramine, EDTA, epinephrine, 
ergonovine, erythromycin, fibrinolysin, hydralazine, metaraminol, 
nitrofurantoin, novobiocin, and protein (human) as incompatible@ 
In a preliminary study (4?), it found that corticotropin, 
hydrocortisone sodium phosphate, and hydrocortisone sodium 
succinate were physically compatible \vith protein hydrolysate, 
but methylprednisolone sodium succinate was physically 
incompatible .. 
Williams and f1Ioravec (I-J-8,L~9) and Fov-rler (50) have 
reported several drugs as incompatible vvith protein hydro--
lysates, based on the recommendation from the manufacturer 
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that· no drugs be added to the solutions or that only certain 
diluents be used.. These studies list only these Cl.rugs as 
compatible with protein hydrolysates: alcohol, ascorbic ncid, 
vitmnin B complex, and thiamine.. Among the drugs list as 
incompatible, it is interesting that these have been listed 
a.s incompatible: corticotropin, calcium gluconate? cortisone 
s.cetate, heparin sodium, insulin (regular), magnesium sulfate, 
., , I .. 
. tl.yo.rocort; J.. sone sodium succ:Lnat:e 7 cyanocobalamin; and phyton-
adione .. 
Cohon (51) mentions that manufacturers recommend that 
ocher drugs not be added to protein hydrolysates.. He cautions 
that ;protein binding may occur, particularly vJith antibiotics .. 
.A most comprehensive examination of eled;rolyto com-
patibility ·with 8 .. 5?6 synthetic amino acid solutiona has been 
performed by Collin, §!~ .. (52)., Initially 9 they studied 
the follouing electrolytes in these concentrations~ magnesium 
sulfate, 10-LJ-0 mEq/I,, potassium phosphate, 20-100 m.Eq/L? 
calcium gluceptate, 10-50 mEqji,, and sodium bicarbonate, 20-100 
mEq/L.. The reproducible precipitation observed, was identified 
analytically and spectroscopically as a calcium-phosphate 
-------
a - FreAmine, McGa\<V Laboratories, Glendale~ Ca,. 
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complex.. It was found that calcium (as gluceptate) and 
phosphate (as potassium acid) are compatible to some ext;ent .. 
They .fout1d this compatibility problem can be avoided if cal-
cium and phosphate ions are added to the 50% dext;rose and 
8..,596 amino acid solution, respectively, prior to their mixing .. 
The precipitation can also be avoided by insuring that calcium 
ion is the last electrolyte adcl.ed to the :final dextrose-amino 
acid solution.. At least 30 mEq/L of potassium phosphate were 
-vdth l5mEq/L of caleium gltlceptate vvith 
these t'iivO procedures .. 
Burke (58) has elaborated on ten commonly used addi-
tives~ based solely on his own personal experience~ Albumin, 
'J;b.ich iB normally listed as incompatible~ 'l:vB.s .found to be 
stable and clinically effective for at; least 2L~ hours.. Cal-
ci.um is reported_ to be incompatible \:Jith sodium bicarbonate, 
as i,s magnesium sulfate.. Burke also reports that cyanocobalamin, 
and :folic acid are inactivated by ascorbic acid, with cy~noco~ 
balamin also being inactivated by high concentrations of dex-
trose.. He does note that one should conduct his ovm con-
trolled tests prior to admixing any drug in a hyperalimenta-
tion solution,. 
As parenteral nutrition becomes more common in medical 
practice, it becomes imperative that more information be made 
available on possible admixture incompatibilities" Thus, t;he 
object of this study was to determine the compatibility of the 
majority of common additives with a mixture of 590 ml 796 
Protein Hydrolysate Injection U.,S..,P .. and LaO ml 5096 Dextrose 
== 
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Injection U.,S .. P .. A physical .evaluation alone (i .. e .. , observation 
.for precipitation, color change, or evolution of gas) v·rith pH 
monitoring 1..vas used in the preliminary study e. Ultra·-violet 
spectroscopy and thin-layer chromatography 1-vere used to aid 
in detecting alterations in the chemical structure o.f the pro-
tein hydrolysate.. These altera·t;ions may be indicative o.f 
unseen chemical incompatibility •. 
II.. EXPERIMENTAL METHOD 
The purpose of this project was to study the a(lmixture 
compatibility of common additives with a mixture comprised of 
590 ml 7% Protein Hydrolysate Injection U.,S .. P .. and 410 ml 50% 
Dextrose Injection U,.S.,P .. (Polynute™ Pack)a,. The e::-..r-perimental 
work was divided into two sections: physical compatibility 
and chemical compatibility .. 
PHYSICAL COMPATIBILITY 
The object of' the physical compatibility study was to 
d.etermtne the maximum concentration of electrolytes \'Ihich rrH:t.Y 
be admixed 'itlith Polynute \vithout physical evidence of i.ncom.-
pat;ibility (precipitation'~ evolution of gas, or color change) .. 
A maximum compatible concen:trati.on \vas evaluated with other 
add.itives, such as select;ed vitamins, insulin, and heparin, 
Each liter of Polynute \vas prepared by infusing 410 ml 
of the 50?6 J)extrose Injection into 590 ml of the 7% Protein 
Hydrolysate, utilizing:the transfer set provided in the 
Polynu.te pack.. This mixed solution vms incorporated into 
the physical study \vithin. eight houx·s as recommended by the 
manufacturer's literature .. 
Each additive-hydrolysate combination was prepared 
in duplicate, utilizing 25 ml quantities in 50 ml erlenmeyer 
a- Cutter Laboratories, Inc .. , Berkeley~ Ca .. 
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flasks for each concentration-combination" The transfer of 
additives vvas made ,,,ith graduated pipettes.. The resulting 
solutions 'I:Jere stored at room temperature (22° C) under normal 
fluorescent room lighting" Physical evaluation was basecl on 
visual examination and pH readings taken at intervals of one, 
four, eight, and twenty-four hours after admixture.. ~!he pH 
readings 1.vere made using a Corning pH meter, l'1odel 7a .. 
Calcium gluconateb, magnesium sulfatec, and potassium 
:phosphated~ ·we:r:e the electrolyte additives selected for this 
study.. These electrolytes were first evaluated individually 
':Iith Pol;y-nute... Follovving this, combinations of the electro-
lytes tvere added to the Polynute solution, starting at a con-
cen.trat:ton of 'l- mEg/f..~., then in increments of 10 mEq/L to c, 
level of 100 rnEq/L or until physical evidence of incompati.~ 
bil:i:t;y '1.1\Tas observed .. 
The follo1ving vitamins v.rere evaluated for physical 
compatibility: vitamin B complex 'tvith C (Solu B Forte8 ), 
folic acid (Folvitef), phytonadione (Aquar1ephytong), 
a - Corning Scientific Instruments, Corning, N .. Y., 
b Pasadena Research Laboratories~ Pasadena 1 Ca,. 
• c - Eli Lilly and Company., Indianapolis? Ind .. 
d McGaw Laboratories, Glendale, Ca~ 
The potassitun phosphate used in this study contained 
potassium dihydrogen phosphate 0,.9 Gm and potassium 
monohydrogen phosphate L~ .. 7 Gm in each 30 mL. All future 
references to potassium phosphate will indicate this 
information .. 
e - The Upjohn Company., Kalamazoo, t1ich .. 
f - Lederle Laboratories, Pearl River, N .. Y .. 
g -· Merck Sharp and Dohme, West Point, N .. Y .. 
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cyanocobalamin (Rubramin PCa), and multiple vitamin infusion 
b (M .. V .. I., ).. Each vitamin was evaluated individually with each 
of the electrolytes and in combination with the maximum con-
centration of electrolyt;es found to be compatible .. 
Regular insulin (Iletinc) and sodium hepar:Lnd were also 
evaluated in combination with maximum compatible concentrations 
of electrolytes and vitamins .. 
Cluxton ( lf-1-~) has calculated the sample size required 
for each sample ~for a t;wo-tailed significance level of 5 per-· 
cent to be approximately three.. :f.lhis is assuming that 10% of 
th-s aa.luixrl.tres we prepare are incompatible., If -vm assume that 
5~'j of the admixtures are incompatible, this results in a sample 
size of less thaa twoe During tbis physical evaluation:: a. 
sample siz9 of tvJO (i.,e.,, duplicate) vms used for each com-
bination; hovJever, during the chemical analysis, n=3 vms used .. 
Cluxton further suggests that the two following assumptions 
be made: 1) if a high concentration of an ingredient is com .. 
patible, a lesser concentration 'iivill also be stable and 
2) order of add.ition is not important.. ~[lhe later assumption 
is, of cmlrse? not valid, especially in light of the report 
of Collin, .§t .§1.." ., but essential becau.se of the magnitud(:~ 
of the combinations that develop with the variation of the 
order of mixing,. A ranc1om order \1JaS selected and maintained 
a E& RG Squibb and Sons, New York, NQ Y~ 
b U .. S .. V .. Pharmaceutical Corp.,, Tuckahoe~ N .. Y .. 
c - Eli Lilly and Compa.ny, Indianapolis, Ind .. 
d - Invenex Laboratories? San Francisco, Ca~ 
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during the stu(ly., 
CliFMICAL COMPATIBILITY 
Since pH change, clarity of solution, precipitation, 
or color change often fails to detect alteration or inact:L~­
vation of ingredients, ultra-violet spectroscopy (U .. V") and 
·thin-layer chromatography (TLC) were employed to elucidate 
possible chemical changes that may have taken place .. 
~~Y&.-~Eectros~oBY 
U., V.. absorption spectra ""ere obtained utilizing the 
3s.uch and Lomb Spectronic 600a double beam spectrophotometer .. 
_1_ Liner/Log Varicord 4-3b reco:r•der provideo. recordings of the 
Sarnples collz 
using a <1u.eterium lamp to provide ·the incident- beam 'l.vave-
length range of 220 to 320 nanometers, 
The same vitamins, calcium gluconate, and potassium 
phosphate ·v1ere examined spectrophotometricall;y·,. Nagnesium 
sulfate clid not exhibit any compatibility problems 1,/ith other 
electrolytes and, therefore, was not considered.. Because of 
the nu.mber of additives present when insulin and heparin were 
ao..mixed, it vra.s felt any spectrophotometric result liJOulct be 
inconclusive.. Therefore, these combinations ·were not examined 
spectrophotometrically .. 
a - Bauch & I.omb Optiea-l-8-empa-n-y-..,---Ro·che-st-er,----N.....--Y." 
b - Photovot Corporation~ Ne1-v York, N .. Y .. 
c - Perkin-Elmer, Coleman Instrument Division~ r1a;)ll;vood, Ill .. 
= ~ 
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Aqueous dilutions of the Polynute v1ere made to 
determine the concentration required to obtain absorbance 
values of 0 .. 3 to Oo9.. This dilution was used as the standard 
by 11vhich all subsequent spectra were compared.. All admi:x:ture 
combinations \vere examined at this dilution concentration 
regardless \IIJhether the additive vJas spectrophotometrically 
decipherable at that concentration .. 
Tt; 1t1as decided to examine each vitamin individually 
against each selected electrolyte solely at therapeutic 
concentrations and in combinatiion (both calcium and phosphate) 
at: t;l1erapeutic concentration and a maximum compatible con-
cerrtrati.on.. Each reference contained water, electrolyte and 
·trolyte(s), and vitamin., This allm'ls scanning for the Polynute 
onJ.y·~ The references -vmre prepared singly and the samples i.n 
triplicate.. T.lH3 respective samples \vere examined at one? four~ 
eight, and t',,renty-fou:r hours.. This was facilitated by removal 
of 2G5 ml from each sample and its corresponding reference 
and diluting with distilled water to 50 ml.. The results o.f 
the spectrophotometric measurements of these admixtures \vere 
compared vrith the standard spectra to a.etect any alteration 
in the protein hyd:rolysate.. If there 'ltvere any alterations in 
spectra, additional combinations vmre examined to· determine 
.further which additive may have been responsible for the 
spectral change .. 
THIN -~LAYER CHROMATOGRAPHY 
_......,---~-----
Basic methods used in this TLC procedure \•!ere developed 
23' 
by ]!rye (53) in his i.nvestig1:1,tion o.f degradation products 
of ·the amino acids in .foodstuffs derived .from soybean meal~ 
Changes in the procedure ·were made to accommodate the Polynute .. 
Plate§_.. Pre-coated glass TLC plates of cellulose 
(without .fluorescence indicator )a. ·were used.. The 20 x 20 em 
plates had a layer thickness of 0~10 mm~ 
~cin~-~~ut.nment~ Drummond microcapillariesb of 
25 microliter capacity vv-ere used.. Application of approxi·-
mately 0 .. 5 microliter on the plate was facilitatecL by touch-~ 
iT:g the capillary tip to surface of' the plate in such a 
mar...ner -~hat ·the spot size was never larger than 2,.0 mm,. A 
DeSago.. spotting tomple.te v::G.s used .. 
ground glass tops 'IJTere used,. To insure saturation, two 
sheets of 20 .. 5 em filter paper0 i.vere used to line two sides 
of the tanlc.. A maximum of tNo TID plates could be developed 
in each solvent system at one time .. 
Jis~alization~~~tw An }J1sco-Calabd spraying 
apparatus \:rhich utilized a positive pressure source was used 
to coat the plates v.Jith the developing solution, A distance 
---·---
a- E9 Merck and Coo, Darmstadt, Germany; marketed by~~ 
Laboratories, Elmsford, N,. Y .. 
b- Kensington Scientific Corp .. , Emeryville, Ca .. 
c - Braun-Yillecht-Hermann Co .. , San Franc:i-sco, Ca .. 
d - Metheson Scientific~ Hay-\vard, Ca.,. 
of' 20 to 25 em \-'las maintained bet\-veen the plate and sprayer. 
;oryi:~g crvei_!.. A Thelco Model 27a was used to dry the 
TLC plates after developing in solvent system I and solvent 
system II.. A setting of' 3 .. 5 maintained the oven at constant 
temperature of' 100° c.. Reducing the setting to 3.,0 resulted 
in a temperature o.f 80° c.. This setting was used .for the 
drying o.f the plates after spraying. 
Chemicals and Reagents.. The solvents and chemicals 
used were of reagent grade or better.. They \vere used directly 
•;Iithout further attempts at puri.fication .. 
Stemvise Procedure 
1.. Spot approximately 0 .. 5 microliter on the ~:LC 
plate approximately 1 .. 5 em from the bottom, 
2 em from the right ed.ge.. Since the spot · 
size should be kept belm'' 2 mm in diameter, 
a hair dryer was used to dry the spot and 
prevent its spread .. 
2.. The plate is care.fully placed in the first 
solYent system.. The tank has previously been 
.filled and allowed to equilibrate., Approxi--
mately 80 to 100 ml of solvent system I is 
sufficient to fill the developing tank .. 
Develop for 8 hours .. 






- -- ·-·---------·----------- -
Solvent System I: 
2-propanol ~ o .. ~ .. 0 
Butanone • .. .. .. .. .. .. 
1 N Hydrochloric acid 
.. <> 60 parts 
.... 15 parts 
.. ,. 25 parts 
25 
Remove the plate from the solvent system I and 
dry in the oven at least 5 minutes at 100° c 
to insure removal of all traces of hyc1rochloric 
acid .. 
L~.. AlloV>J the plate to cool, then repeat step 2 in 
solvent system II.. Develop for 6 hours,. 
Solvent System II: 
2-methyl-2·-butanol .. 






.. .. .. 
·"' 
20 parts 
Propanone .. 6 .. .. .. .. 
" 
.. 10 parts 
M~·f-:h,::tnn'l "'~V\.1' _____ .....,. 
.. 
" 
.. .. @ .. ;;. .. .. 
r; -n~r-+:~ 
./ ]:' ....... ...._ ..... _ 
~Vater .. .. .. .. 
" 
.. e ., 
" "' 
15 pa:r:t:~1 
Aqueous ammonia (2796) ., 
"' 
5 parts 
5 .. Agai.n dry the plate at 100° c for five minutes 
a...'Yld allow to cool .. 
6., Spray the plate in the hood with .freshly pre-
pared cadmium acetate-ninhydrin spray reagent .. 
l 
Prepare cadmium acetate solvent by adding 
0 .. 5 Gm of reagent grade cadmium acetate 
to a mixture of 50 ml of waterand 10 ml 
glacial acetic acid.. Add enough propanone 
to prepare a final volume of 500 ml.. For 
use, enough solid ninhydrin was added to 
proportions of the above solution to make 
the final concentration of ninhydrin equal 
to 0 .. 2% -vv/v.. It v'las found tha·t; 100 ml Has 
a convenient quantity to prepare when 
~ 
developing a small nmnber of plateso 
7o Dry the sprayed plate for fifteen minutes at 
80° C to effect visualization.. The plate 
should be dried on their sides, not flat. 
8.. Document t;he chromatogram by recording the 




The physical compatibility evaluation of selected 
electrolytes and vitamins in Polynute was based on visual 
examination and pH readings.. These were taken at intervals 
of one, four~ eight, and t"tl!enty-four hours i'ollowing ad.t'nix-
ture.. All determinations were performed in duplicate.. It 
was observed that there was little variation in pH bet\'leen 
:!.n:';ervals, therefore, all pH readings reported_ are averages 
of the eight readings~ unless otherwise stated., Without 
add.itives, Po1y.aute had a pH of 5"22,. If, during any of 
these time examinations, physical compatibility ;,vas observed., 
the combination was considered incompatible .. 
The electrolytes represented on the left margin of 
Tables II to XI were admixed first with the Poly~uteo 
Qu.antities of electrolytes shown in these tables are the 
amounts added. to the Pol;ynute and do not includ0 those amounts 
alreac1y present.. In these tables, the symbol 11 0 11 is used to 
denote the absence of any visual change in the solution and~ 
therefore~ denotes physical compatibility.. The symbol 11X11 
signifies the formation of a visible precipitate, thus 
physically incompatible~ 
There appears to be no physical incompatibility with 
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the following combinations of electrolytes: calcium 
gluconate-magnesium sulfate (Table II) and potassium 
phosphate-magnesium sulfate (Table IV). A maximum com-
patible concentration \'liaS. reached with the calcium gluconate-
potassium phosphate combination (Table VI).. Reversing the 
order of mixing did not appear to affect the physical com-
patibility except in the case of calcium gluconate and 
potassium phosphate (Table VIII)~ The addition of magnesium 
sulfate to the calcium-phosphate combinations did not appear 
to al-l:;er the appearance of the solutions (Table X).. As the 
concentration of the additive increase, there \•JaS a corre-
s'_9onding change in the pH of i.;he Polynute, reflecting the pH 
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Table II.. Physical Compatibility of Calcium 





Magnesium Sulfate (mEq/L) 
Table III~ pH of Solutions Containing Calcium 
Gluconate and Magnesium Sulfate, Admixed ln 
. Poly.nut e .. 
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Magnesium Sulfate (mEq/L) 
Table IVe Physical Compatibility of Potassiwn 
Pnosphate and Magnesium Sulfate, Admixed in 
.Polynute .. 
*Readings taken at one and four hours only .. 
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Magnesium Sulfate (mEq/L) 
Table V.. pH of .Solutions Containing Potassium 
Pnosphate and Magnesium Sulfate, Admixed in 
Polynuteo 
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Potassium Phosphate (mEq/L) 
~~able VI.. Physical Compatibility of Co.lcium Gluconate and 
Po-tassium Phosphate, Admixed in Polynute .. 
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Table VII., pH of Solutions Containing Calcium Gluconate ancl 
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Table VIIL. Physical Compatibility of Pot.assium 
Fnosphate and Calcium Gluconate, Admixed in Polynute .. 
(Note order of mixing reverse of Table VIO) 
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Table IXo pH of Solutions Containing Potassium 
:Phosphate and Calcium Gluconate, Admixed in Polynute .. 
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Table X.. I1lysical Compatibility of Calcium 
Gluconate and Magnesium Sulfate i.IIJith the 
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Table XI.. pH of Solutions Containing Calcium 
Gluco:n:=:rt;e and f1Jag;nesil.un Sulfate with addition 




The vitamins were examined at two concentrations~ An 
order of mixing was chosen at random and maintained throughout 
the procedure. The calcium gluconate was added first, then 
potassium phosphate 9 magnesium sulfate, and the vitamin.. As 
with the electrolytes, as the concentration of the vitamin 
was increased, the pH of the solution reflected the pH of the 
additive.. The addition of the vitamin did not alter the con-
centration at which each electrolyte 'tvas found to be compatible 
(Table XII) .. 
INSULIN AND HEPARIN 
Hegular insulin was added to the Polynute in increments 
of 20 units to a level of 100 units/L.. Insulin vvas admixed 
last with the following additives already present in the 
Polynut;e: calcium, magnesium, phosphate, phytonadione~ cyano-
cobalamin, and folic acid., One set was prepared "i.vith M .. V .. I .. 
and one with Solu B Forte, assuming that both vitamin supple ... 
ments would not be administered simultaneously.. These admix-
tures 'tvere prepared by adding the components to the Polynute 
in the following sequence: calcium gluconate, potassium phos-
phate, magnesium sulfate, M,.V .. I .. or Solu B Forte, folic acid, 
cyanocobalamin, phytonadione 7 and finally the insulino 
Heparin sodium was added to the Polynute in similar 
sequence and used with the insulin? adding the heparin as the 
last aclditive.. A concentration of 1000 mcg/L was used.. The 
addition of regular insulin or heparin sodium did not alter the 
appearance of the solution (Table XIV, XV).. There was also 
little change in the pH of the solution .. 
~-
Solu B Forte 
5 ml/L 
10 ml/I~ 
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Table XII.. Physical Compatibility of Selected 
Vitamins in the Presence of Calcium? Nagnesium, 
and/or Phosphate, Admixed in Polynuteo 
----- - ---- -- --- - ------- ----------------- ------ -- -- - -----
Solu B Forte 
· 5 ml/L 
10 ml/L 
· Folic· -J\ciCL 
0 .. 5 mg/L 
5·mg/L 
C:7an.oco balamin 
- . 300 mcg/L 
1000 nmg/L 
:f?hyt onadi one. 
J.o·mg/L 
50 mg/L 
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Table XIII.. pH o.f Solutions Containing SeJ.ected 
Vitamins in the Presence o.f Calcium, l\1agnesium, 












Folic Acid 5 mg/L, 
B-12 1000 mcg/L, 
K-1 10 mg/L, 
plus: 
Solu B Forte 
10 ml/IJ 
4-l 
Table XIV.. Physical Compatibility and pH of 
Polynute, .Admixe·d with all Selected Vitamins 
in the Presence of Calcium, Magnesium, and/or 






Calcium 20 mEq/L 
Phosphate· 20 mEq/L 
Folic Acid. 5 mg/L 
B-12 1000 mcg/L 
K-1 10 mg/L 
plus: 







Sodium unit; s/L 
Table XVo Physical Compatibility and pH of 
Poly.nut;e, Admixed with all Selected Vitamins 
in the Presence of Calcium, Phosphate, and 




Continuous U .. V .. absorption spectra were obtained for 
triplicate additive-Polynute samples.. An aliquot was removed 
from the samples and diluted for scan at one, four 9 eight, and 
twenty-four hours after admixture. 
In preparation of the references for the calcium-
phosphate series \'rith the vitamin ad.ditives, it was found that 
concentrations of electrolytes compatible in the Polynute are 
incompatible in aqueous solution.. The problem was to combine 
all those additives found in the additive-·Polynute sample, in 
the reference such that the spectrum read by the spectrophoto-
meter would be that of the Pol;ynute only.. U .. V .. absorption \vas 
· measured for (l) water alone, (2) dextrose and 1vater, and 
(3) water containing the individual electrolytes (i.e .. 1 calcium 
gluconate a:r1d potassium phosphate).. No, U .. V .. absorption was 
observed in any of these three solutions.. This would indicate 
that dextrose and these ions do not absorb U.V. light at those 
concentrations required for scanning.. Therefore~ when calcium 
and phosphate were both present in a test admixture, they were 
omitted from the aqueous reference solution.. This was neces-
sitated by the limited solubility of calcium phosphate in water .. 
This procedure permitted obtaining the absorption spectra of 
Polymxce.. The Beer's Lm·T Plot for Polynute and U .. V .. absorp-
tion spectrum of Polynute are shown in Fig. 1 and 2, respec-
tively .. 
= ~= 
- - - ---- -- - -- ---------- ------- ------
- ·- -···~ ~~---- ~-·--- -----~--
1 .. 2- .. 
1 .. 0 --
l 
0 .. 6 .L 
. 0 .. 4 .. 







2 3 4 5 
ml/100 ml .. 





U.,V., Spectrmn of Polynute (i\ max 276) at 5 ml/100 ml 
;:-====-~---=-==-===-c===--:c -------- --- ----- ---------- --- -------------------- -
1~6 
Pnytonadione, Folic Ac.i.d, and C;yanocobalami.:£ 
The preliminary study 1,11as conducted in the .follo1,ring 
manner.. Each vitamin was admixed with each electrolyte singly, 
and in combination (calcium and-phosphate) at a therapeutic 
concentration and a maximum compatible concentration. These 







t~J"ater and phyt;onadione 10 mg/L 
Polynute, phytonadione 10 mg/L, 
calcium 20 mEq/L, and phosphate 
20 mEq/L 
water and .folic acid 5 mg/L 
Polynute, .folic acid 5 mg/L, 
calcium 20 mEq/L~ and phosphate 
20 mEq/L 
tvat er ana. cyanocobalamin 1000 mcg/L 
Polynute, cyanocobalamin 1000 mcg/L, 
calcium 20 wEq/L~ and. phosphate 
20 mEq/L 
If there w·ere no alterations in spectra, then that additive 
~tvas considered apparently compatible with the Poly.o.ute.o This 
was t;rue v1ith phytonadione (Fig., 3), .folic acid (Fig .. L~)? and 
cyanocobalamin (Fig$ 5)@ 
These scans represent samples at intervals of one and 
eight hours after admixture with potassium phosphate 20 mEq/L 
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Fig .. 3. U .. V .. Spectra of Po1~'lute when admixed v.Jith potas~3ium phosphate 20 mEq/L, 
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Fig.. 5 .. 
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U., V. Spectra of Polynute vrhen admixed with pqtaBsium phosphate 20 mEc~i/L, 
calciu.rn gluconate 20 mEq/L, ar+d c~yanocobalamin 1000 mcg/L .. 




The follo1Hing combinations of references and samples 
\vere prepared for M,. V .. I .. , 10 ml/L: 
I. Reference: 
Sample: 
water and M .. V .. I .. 
Polynute, M.V~I., calcium 20 mEq/L, 
and phosphate 20 mEq/L 
II., Reference:· water and M .. V~I .. 
III .. 
IV .. 
Sample: Polynute, M .. V .. I .. , calcium 5 mEq/L, 





water, M .. V .. I .. , and phosphate 10 mEq/L 
. Polynut e, M .. V., I .. 7 and phosphate 10 mEq/I1 
\.~Tater, r1. V .. I .. , and calcium 5 mEq/L 
Po1ynute, M .. V .. I .. , and calcium 5 mEq/L 
H .. V .. I .. exhibited a hypsochromic shift from278 nm to 267 nm 
in the solui.-;ion admixed with bo·t;h calcium gluconate, 20 mEq/L., 
and. potassium phosphat;e, 20 mEq/L (]'ig .. 6,'/).. i•ne 1ower·:Lng 
of the electrolyte conce1xl:;rations did not alter the observed 
effect r-rr· \-J.g., \~ith potassium phosphate, 10 mEq/L, a 
second A max is detectable at 261 nm at the one hour interval 
(Fig .. 10,11). There appears to be a growth of this peak over 
a time period, \oJhich apparently influences the observed shift .. 
This effect is also observable \vi th calcium gluconate, 5 · mEq/L 
(li1ig .. 12,13) e In this set, the shift is more easily detect-
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Figo 6o U., V .. Spectra of Pol;ynute \vhen admixed ~tvith potassium phosphate 20 mEq_/L, 
calcium gluconate 20 mEq_/L, and MeV.I~ 10 ml/Lo 
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Fig .. 7. U., V: .. Spectra of Polynute 'vhen l aclt''ll~~xed with pota;gsium phosphate 20 mEq/L, 
calcium gluconate 20 mEq/L, and MoV~I. 10 ml/L .. 
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Fig .. 12., 
1 hour 4 hours 
U .. V .. Spectra of Polynute vJhen admixed ''iith calcium g1uconate 5 mEq/L 
and H .. V .. I .. 10 m1/L.. . 
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Figo 13. u .. v .. Spectra of Po1ynute 
and JYI,. V .. I., 10 m1/L .. 
when adrr.1ixed vJ'ith ca1eium g1uconate 5 mEq/L 






Solu B Forte 
The follo•Hing combinations or references and samples 









water and Solu B Forte 
Polynute, Solu B Forte, calcium 20 mEq/L, 
and phosphate 20 mEq/L 
water and Solu B ]'ort e 
Polynute, Solu B Forte~ calcium 5 mEq/L 
and phosphate 10 mEq/L 
I -
~>'Tater, Solu B Forte, and phosphate 
10 mEq/L 
Polynute, Solu B Forte, and phosphate 
10 mEq/L 
water, Solu B Forte, and calcium 5 mEq/L 
Polynute, Solu B Forte~ and calcium . 
5 mEq/L 
~'Then Solu B Forte is added to Polynute in t;he presence of cal-
cium. gluconate ~ 20 mEq/L, and potassium phosphat·e? 20 mEq/L 
(Set I), a three-peaked spectrum is obtained (Fig .. 11.~,15) .. 
There is little ehange from the one to the four hour interval, 
but at the eight hour interval, a hypsochromic shift is evid.ent .. 
At lower electrolyte concentrations, the 231 nm-peak is more 
pronounced at the onehour interval (Fig .. 16, 17) .. The shift 
to shorter -vvaveleng,ths is again evident.. When in the presence 
of potassium phosphate, 10 mEq/L~ alone~ there is a change of 
spectra (Fig.. 18)., This tV~TO peaked scan has no peak at the 
251 nm observed in those scans with both electrolytes.. At the 
:four hour interval, the 251 nm peak becomes more evident.. The 
absorbance increases with time until it surpassed the 232 n.-·n 
peak at 24 hours (Fig .. 19).. This does not develop with calcium: 
gluconate, 5 mEq/L, as its spectrum is very similar to those 
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U .. V. Spectra of Polynute 'ivhen adlo.ixed with potassium phosphate 20 mEq/L, 
calcium gluconate 20 mEq/L, and Solu B Forte 10 ml/L .. 
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Figo 17., U .. V .. Spectra of Polynute vJhen adra.ixed 
calcium gluconate 5 mEq/L, and Solu B 
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Thin-Layer Chromatography (TI,C) analysis vms conducted 
with duplicate samples, each prepared every eight hours to 
facilitate running a sample and a control plate containing 
Polynute only, simultaneously .. · Due to the t\".TO plate capacity 
of the DeSaga-Heidelberg developing tanks, only one sample..,. 
control set could be developed at each interval., The four 
hour interval after admixture vms chosen as the sample time 
for the TLC analysis$ 
Of the combinations that exhibited spectral changes, 
sa11ples from the follOIJ'Jing mixtures vvere examined: 
I.. Polynute \IIJhen ad.mixed with calcium gluconate 
5 mEq/L and Solu B Forte 10 ml/.L 
II.. Polyrmte when admixed ;~,lith calcium g1uconate 
5 mEq/L· and H., V,. I.. 10 m1/I, 
III.. Po1;ynute when admixed with potassium phosphate 
10 m:F~q/L and Solu B m:>rte'IO ml/L 
IV. Pol;ynute when admixed with potassium phosphate 
10 mEq/L and M .. V .. I .. 10 ml/L 
V.. Polynute when admixed with calcium gluconate 
20 mEq/IJ, potassium phosphate 20 mEq/L, and 
Solu J3 Forte 10 m1/L 
VL. Polynute when admixed with calcium gluconate 
20 mEq/L, potassium phosphate 20 mEq/L, and 
M .. V .. I .. 10 ml/L 
Single plates of the following mixtures \vere also analyzed: 
VII.. Polynute vvhen admixed ·with calcium 20 mEq/L, 
phosphate 20 mEq/L, folic acid 5 mg/L, cyano-
cobalamin 1000 mcg/L, phytonadione 10 mg/L, and 
Solu B Forte 10 ml/L 
VIII.. Polynute when admixed with calcium 20 mEq/L, 
phosphate 20 mEq/L, folic acid.5 mg/L? cyano-
cobalamin 1000 mcg/L, phytonadione 10 mg/L~ 
and ~~J .. V .. I .. 10 ml/I, 
Each additive-Polynute combination resulted in the same 
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chromatographic pattern observed in Figure 22.. The control 
and sample chromatograms could not be differentiated visually~ 
Examination of the TLO pla·tes under ultraviolet light did not 
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TLC plate spotted with 0~5 microliters of Polynutet 
ft d 1 t · th 0 2°L · nh d · · a· er eve opmen wl .. .. ;o nJ_ y. rJ.n spray .. 
IV .. DISCUSSION 
It has been noted that the pH of the parenteral 
solution is an important factor in the compatibility of 
admixing essential additives~ The pH of the additive, its 
concentration, and the pH of the basic parenteral nutrition 
solution all contribute to the final pH,. The presence of a 
physical incompatibility can also alter the pH of the solu-
tion (4?) which could also affect other o.dditives present., 
Certainly, the stability of various common additives at the 
Polynute must ahvays be conside:recl,. 
The compatibility of ·calcium gluconate and potassium 
phosphate in protein hydrolysate lS affected by the order of 
mixing.. This effect can be seen in the maximum compatible 
concent;ration obtained with each sequence.. Although a com-
plete study was not performed on t;he effect of order of mix-
ing on these t-vm ions, a trend could be distinguished .. 
Collin and co-vwrkers (52) have studied the compatibility 
of calcium gluceptate and potassium phosphate in 8% amino 
acid solution (FreAminea) and have made specific recommenda-
tions~ They report the calcium and phosphate ions should be 
added to the 5096 dextrose and Fre.Ainine units respectively~ 
prior to their mixing, or that calcium ion be added as the 
a ·- McGavv Laboratories 9 Glendale, Ca. 
~-
last electrolyte to the FreA.m.ine-d.ex"i;rose solutiono 
Certain drug previously reported as incompatible 
with protein hydrolysates (1~8,1~9,50) were found. to be 
physically compatible in this study.. .t-\mong these were 
heparin sod.ium, regular insulin, magnesium sulfate, c;>ran.o-~ 
cobalamin, and phytonadioneo 
I 
The electrolyte concentrations alread.y present in 
the protein hydrolysate shoulcl ahvays be considered \vhen 
preparing a parenteral nutrition solution in the clinical 
setting.. In addition to the concentrations added. in this 
stud;y·, Polynute contains the follmving concentrations o:f 
the selected. electrolytes: calcium 4 mEq/I,, mag11esium 
1 mEq/I,, and. phosphate 8 ·mEq/L .. 
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:lJ:Ihe evaluation of the U .. V.. spectra was be. sed on altere.-
tion :l.n the scan, which is apparently du.e to a chemical inter-
action.., ~A decrease or increase at the absorption maximum 
'(/-. ma.x), shift of A max, or absenc~e or presence of a secondary 
. peak(s) vle:C'e noted in the results. A decrease or increase at 
t-.max vJouJ.d. be indicative of a decrease or increase, respec-
tively~ of concentration. A shift o.f' Arne._"< and absence or 
presen.ce of secondary peaks would be ind.icati ve of a change 
in molecular or electron configuJ?at_ion of the .formulation .. 
Because of the expei·imental design employed, when both calcium 
and phosphate \vere required for the reference~ the results 
obtained may actually be a composite of both Polynute and the 
two electrolytes.. Hov1ever" both calcium and phosphate alone 
do not absorb U. V. light a:~ the concentrations used in the 
73 
scHns .. 
Blackburn (55) reports that the majority of amino 
acids shO\.v no Hbsorption over the range 250 to 320 nm, and 
phenylalanine, tyrosine, and tryptophan together are 
responsible for the u .. v .. absorption of the protein solution,. 
Since tyrosine and tryptophan. absorb to such a great degree,· 
it has been reported thHt absorption due to phenylalanine 
can be neglected.. Rao (57) reports that the absorption of 
these amino acids occurs at about 260 to 280 nm.. · Goodwin 
and Morton (54) pointed out that protein hydrolysates can 
be treated as t"To-component systems for analysis by spectra-
photometry.. They assume that neither the presence of the 
other amino aciCl.s nor the mode of the linkages significantly 
distorts:or displaces the tyrosine-tryptophan absorption .. 
Coulter and co-vrorkers (56) concluded that there is no dis-· 
placement due to the peptide linkage. However, Rao (57) 
reports some absorption from 200 to 2LJ.Q nm., 
The optimum concentration required for continuous 
U.V .. absorption spectra for folic acid, cyanocobalamin, and 
phytonadione was too high to be considered therapeutic and, 
therei'o.re, was not examined.. However, at therapeutic con-
centrations., there was no apparent effect on the Polynute 
spectra .. 
Due to the limitations of the spectrophotometer, dilu-
tions of the admixed solutions vvere required to obtain the 
U .. .V .. scans.. If a chemical interaction were to be concentra-
tion dependent, then this may have affected its detection .. 
-~-~~------------------
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One must also consider the possibility of such concentration 
dependent interaction as being reversible or irreversible .. 
Those additive-Polynute combinations that exhibited 
apparent changes in the u .. v .. analysis were prepared again 
and spotted on TLC plates, :four hours after admixture~ This 
was done to determine if the altered spectra were due to a 
demonstrable chemical interaction or change.. The TLO tech-
nique employed provides information on 17 of the amino acids 
and peptides present in the protein hydrolysate.. Nothing can 
be said about the chemical integrity of the other additives, 
the remaining amino acids, and/or the peptideso 
Solu B Forte and M .. V .. I .. were admixed with potassium 
phosphate and calcium gluconate at a. concent:r:·ation of 20 mEq/L 
each" There was no visible change in the chromatogram or Rf 
values,. Both vitamin additives were added to the electrolytes 
individually and this resulted in no changeo The addition of 
all the additives in concentrations used in the physical study 
(Table 17) did not alter the results .. 
On the basis o:E' the data presented here, ;Lt appears 
-that the major compatibility problem in protein hydrolysate-
dextrose solutions vdll be that of high concentrations of 
calcium and phosphate ion.. The compatible concentration ranges 
for these electrolytes has been mapped in Table VI. If a 
precipitation of calcium phosphate is to occur, it will be 
manifested almost immediately after admixture of the .components .. 
It has been demonstrated that greater concentrations of these 
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is added last (see Table VIII,).. The reason for this 
phenomenon remains unclear.. The maximum compatible con-
centra·!:;io.ns does not seem to be affected by the addition 
of the other drugs included in this work. Common additives 
such as vitamins, insulin, heparin, and magnesium have not 
been shoilm. to produce physical incompatibilities, in usual 
therapeutic concentrations .. 
Although alterations inU .. V,. absorption spectra of 
Pol;y-nute were seen when in the presence of M., V .. I.. (see 
Fige 6 to 13) and Solu B Forte (see Fig& 14 to 21), there 
'tias no confirmation of this chemical interaction" by TLC .. 
V.. Sill1JYI.ARY AND CONCLUSION 
In total patient care, there is a definite 
relationship bet\veen proper nutirition and maintenance 
of health~ Certainly the role of proteins, calories, vita-
ruins~ and minerals have been well documented,. Their impor--
-cance • • +'. ;.J ~s raagn1..~... ~eu in instances of trauma and infection .. 
Parenteral nutrition has developed int·o a practical method 
o:t .feeding patients unable to take an adequate diet.. Yet, 
if in an attempt to pro·vide all these essential nutrients 
parenterall.y 9 there is some physico-chemical interaetion 
\vhich destroys the biological effectiveness of an ingredient~ 
then another method of ad..rnini.stration must be initiated .. 
The study of the electrolyte additives indicates 
that admixture of calcium gluconate and potassium phosphate 
in·combiilation does reach a maximum compatible ·concentration 
at about 20 mEq/L of each ion~ As a rule, the addition of 
calcium ion last in the preparation of a hyperalimentation 
solution should prevent problems, providing concentrations 
do not exceed those normally considered therapeutic.. The 
ac1..dition of calcium gluconate last has resulted in an increase 
o.f the maximum compatible concentration to L~O mEq/L of each 
ion .. 
The alteration of U~V .. spectra indicated that vitamin 
B complex vJith C (Solu B Forte) and multiple vitamin infusion 
- -- -- ---------
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(M.V.I .. ) may be chemically incompatible with Polynute.. This 
conclusion \-Jas not substantiated by thin-layer chromatography .. 
Additional studies will have to be performed to elucidate 
.this point further .. Under the conditions set forth in this 
study, it appears that folic acid, phytonadione, cyanocobalamin, 
vitamin B complex v1ith c, and multiple vitamin infusion are 
compatible vvith a mixture of 590 ml 7?6 Protein Hydrolysate 
and 410 Ihl 5076 Dextrose (Polynute) in the presence of limited 
concentrations of calcium and phosphate~ 
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